JTCS Medtronic Endurant
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnhart, G. R.
Right arrow Articles by Ferrans, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnhart, G. R.
Right arrow Articles by Ferrans, V. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 83, 618-631, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Bioprosthetic valvular failure. Clinical and pathological observations in an experimental animal model

GR Barnhart, M Jones, T Ishihara, AM Chavez, DM Rose and VJ Ferrans

We compared the clinical, hemodynamic, and morphological findings in 18 young sheep in which porcine valvular bioprosthesis (eight animals) and bovine pericardial bioprostheses (10 animals) were implanted in the tricuspid position. At the time of terminal elective studies (mean of 5.2 +/- 0.2 months after implantation), six animals had ascites, 16 had hepatic congestion, and four had bioprosthetic valvular infection. Hemodynamic studies (n = 10) showed that the tricuspid transvalvular mean diastolic gradients were not different at implantation and at termination of the study (4.7 +/- 0.8 versus 4.9 +/- 0.9 mm Hg); however, tricuspid valve end-diastolic gradients increased from 1.2 +/- 0.6 to 3.9 +/- 0.5 mm Hg (p less than 0.01). Each of the 18 valves had calcific deposits. Quantitative studies revealed that implanted porcine valvular bioprosthesis (n = 7) contained a mean of 323 +/- 165 mg of calcium/gm of dry weight of cuspal tissue, in contrast to 0.2 mg/gm in unimplanted porcine valvular prostheses. Similarly, implanted bovine pericardial bioprostheses (n = 6) contained a mean of 421 +/- 115 mg of calcium/gm of dry weight of cuspal tissue, in contrast to 0.3 mg/gm im unimplanted bovine pericardial bioprostheses. Morphological findings in both types of bioprostheses included calcific deposits, collagen degeneration, leaflet immobilization and retraction, and fibrous sheaths. The latter were more extensive in bovine pericardial bioprostheses than in porcine valvular bioprostheses. We conclude: (1) that the pathological alterations which develop in bovine pericardial bioprostheses are generally similar to those in porcine valvular bioprostheses, but may be more severe; (2) that these alterations lead to physiological and clinical sequelae similar to those of bioprosthetic valvular failure in human subjects; and (3) that young sheep constitute an excellent experimental model for in vivo testing of bioprosthetic cardiac valves.


This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. W. Chung, J. W. Kim, H. R. Lee, Y. D. Kim, and H. K. Chung
Calcification of Experimental Valve Bioprostheses
Asian Cardiovasc Thorac Ann, March 1, 2001; 9(1): 19 - 23.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Le Tourneau, C. Savoye, E. P. McFadden, D. Grandmougin, H.-F. Carton, J.-L. Hennequin, A. Dubar, G. Fayad, and H. Warembourg
Mid-Term Comparative Follow-Up After Aortic Valve Replacement with Carpentier-Edwards and Pericarbon Pericardial Prostheses
Circulation, November 9, 1999; 100(90002): II-11 - II-16.
[Abstract] [Full Text] [PDF]


Home page
J Biomater ApplHome page
K. P. Rao and C. Shanthi
Reduction of Calcification by Various Treatments in Cardiac Valves
J Biomater Appl, January 1, 1999; 13(3): 238 - 268.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Chanda, R. Kuribayashi, and T. Abe
NEW-GENERATION VALVED CONDUIT: AN EXPERIMENTAL STUDY
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 218 - 223.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Vetter, A. Nerlich, U. Welsch, K. Liao, A. Dagge, C. Strenkert, and B. Reichart
TOTAL REPLACEMENT OF THE MITRAL APPARATUS WITH A STENTLESS, CHORDALLY SUPPORTED MITRAL VALVE ALLOGRAFT: AN EXPERIMENTAL STUDY
J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 595 - 604.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. Chanda
Prevention of calcification of heart valve bioprostheses: An experimental study in rat
Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S339 - S342.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Tamura, M. Jones, I. Yamada, and V. J. Ferrans
A comparison of failure modes of glutaraldehyde-treated versus antibiotic-preserved mitral valve allografts implanted in sheep
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 224 - 238.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. P. Gott, Pan-Chih, L. M. A. Dorsey, J. L. Jay, G. K. Jett, F. J. Schoen, J.-M. Girardot, and R. A. Guyton
Calcification of porcine valves: A successful new method of antimineralization
Ann. Thorac. Surg., February 1, 1992; 53(2): 207 - 216.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Gabbay, U. Bortolotti, G. Cipolletti, F. Wasserman, R. W. M. Frater, and S. M. Factor
The Meadox Unicusp Pericardial Bioprosthetic Heart Valve: New Concept
Ann. Thorac. Surg., June 1, 1984; 37(6): 448 - 456.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The American Association for Thoracic Surgery.